Rallybio Corp. (RLYB)
16.64
+0.24
(+1.46%)
USD |
NASDAQ |
Oct 23, 16:00
16.48
-0.16
(-0.96%)
After-Hours: 20:00
Rallybio Total Liabilities (Quarterly) : 3.567M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.567M |
| March 31, 2026 | 4.195M |
| December 31, 2025 | 4.305M |
| September 30, 2025 | 4.627M |
| June 30, 2025 | 5.039M |
| March 31, 2025 | 3.91M |
| December 31, 2024 | 6.454M |
| September 30, 2024 | 8.189M |
| June 30, 2024 | 12.41M |
| March 31, 2024 | 10.20M |
| December 31, 2023 | 9.436M |
| September 30, 2023 | 9.613M |
| Date | Value |
|---|---|
| June 30, 2023 | 8.319M |
| March 31, 2023 | 7.121M |
| December 31, 2022 | 11.12M |
| September 30, 2022 | 11.72M |
| June 30, 2022 | 7.756M |
| March 31, 2022 | 6.317M |
| December 31, 2021 | 6.583M |
| September 30, 2021 | 7.379M |
| June 30, 2021 | 7.435M |
| March 31, 2021 | 6.099M |
| December 31, 2020 | 5.855M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.661B |
| Anixa Biosciences, Inc. | 1.873M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 98.06M |
| Shareholders Equity (Quarterly) | 94.50M |
| Current Ratio | 27.26 |
| Net Debt Paydown Yield | 0.03% |